ROXYBOND FDA approval date

The FDA approved ROXYBOND on 20 Apr 2017.

FDA approval date
20 Apr 2017

Drug identity has not yet been verified against registry records

Also recorded as OXYCODONE HYDROCHLORIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2017-04-20DayROXYBONDFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA209777", "applicant_as_listed_by_fda": "PROTEGA PHARMS", "brand_names": ["ROXYBOND"], "active_ingredients": ["OXYCODONE HYDROCHLORIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20170420", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026